Urinary Tract Infection Testing Market Share Worth $1,027.4 Mn by 2031Download Sample Reports Overview
The Global Urinary Tract Infection Testing Market Size was $574 million in 2021 and is predicted to expand at a CAGR of 6.2%, generating a revenue of $1,027.4 million by 2031.
Impact Analysis of COVID-19 on the Urinary Tract Infection Testing Market
The most prevalent signs of COVID-19 are related to respiratory symptoms, including rhinorrhea, shortness of breath, and cough. According to numerous studies, other organ systems, including cardiovascular, central nervous, gastrointestinal, and urinary systems, can also get involved. Severely contaminated COVID-19 patients exhibit symptoms of UTIs. Antibiotics are used excessively in COVID-19-infected patients due to excessive levels of blood inflammatory markers of bacterial infection. COVID-19 patients can get urinary infections due to inflammation in the urinary tract caused by bacteria.
Global Urinary Tract Infection Testing Market Analysis
Urinary tract infection (UTI) is a microbial infection that causes inflammation of the urinary tract. UTIs can be fatal in some cases, and both females, as well as males, experience UTI symptoms at least once in their lifetime. Timely diagnosis and proper treatment are the most important requirements for deterring complicated UTI conditions. The UTI testing market has gained significant popularity in recent years as it helps in reducing the morbidity and mortality rate associated with urosepsis, especially among geriatric and pediatric population. These factors are estimated to boost the urinary tract infection testing market size in the analysis timeframe.
The rising prevalence of urinary tract infections across the world is projected to drive the urinary tract infection market share during the forecast period. UTIs have a serious financial and emotional economic burden, impacting family as well as personal commitments, sexual health, and quality of life. Moreover, the recurrence rate of UTIs is very high. The repeated occurrence of UTIs can cause urinary sepsis, glandular cystitis, pyelonephritis, and even severe renal failure, leading to death.
However, the false results associated with urinary tract infection testing may hinder the market growth during the forecast period. The rising geriatric population globally may offer ample growth opportunities that will boost the urinary tract infection market size in the coming years. The number of older people worldwide is growing at a dramatic rate. Presently, around 8.5 percent of individuals worldwide are aged above 65 years and this percentage is anticipated to rise to around 17 percent of the world’s population by the year 2050. UTIs are the most diagnosed infections in aging people. Various studies reported that women over age 65 are more prone to UTIs.
Global Urinary Tract Infection Testing Market, Segmentation
The urinary tract infection testing market is segmented on the basis of infection type, test type, end user, test kit, and region.
The infection type segment is further classified into urethritis, cystitis, and pyelonephritis. Among these, the pyelonephritis segment is expected to expand at the fastest CAGR during the forecast period. Pyelonephritis is a type of urinary tract infection associated with the kidney. It generally starts from the bladder and moves upstream to the kidneys. Doctors generally test urine samples for the diagnosis of pyelonephritis in patients. The sample is then checked for the existence of bacteria in the urine. In rare circumstances, the patient is hospitalized.
The test type segment is further divided into urinalysis, urine culture, and susceptibility testing. Among these, the urinalysis segment held the highest market share in 2021. A urinalysis is a type of test that can evaluate various elements of a person's health on the basis of the urine sample. Doctors frequently use urinalysis tests to determine urinary tract infections. Urinalysis analyzes the chemical, visual, and microscopic characteristics of urine. It includes a range of tests that measure and detect different compounds using a sample of urine. These factors are anticipated to boost the urinary tract infection testing market growth during the forecast period.
The end-user segment is further classified into hospitals, diagnostic laboratories and research institutes. Among these, the diagnostic laboratories segment is anticipated to show the highest growth rate during the forecast period. The number of samples tested in diagnostic laboratories is likely to grow during the forecast period. These labs can be public or private and are equipped with expensive instrumentation. There is a requirement for trained and qualified personnel to conduct the tests. Technological advances in data management, as well as diagnostic equipment, are anticipated to further supplement diagnostic laboratories' growth.
The test kit segment is further classified into home test kits and laboratory test kits. Among these, the laboratory test kits segment accounted for the highest market share in 2021. A laboratory test kit can help people to maintain track of leukocytes, pH, nitrites, blood, and other parameters in urine to diagnose UTIs. This test kit offers authentic test results on a smartphone in less time. Moreover, patients can re-check anytime if they are infection-free or not using UTI test kits.
The regions are further classified into North America, Europe, Asia-Pacific, and LAMEA. Among these, the North America urinary tract infection treatment market is expected to hold major market share during the forecast period owing to the increase in prevalence of diabetes and other chronic illnesses and the rise in the number of UTI patients, particularly in the U.S. These factors are anticipated to boost the North America urinary tract infection testing market share during the forecast period.
Key Players in the Global Urinary Tract Infection Testing Market
Some of the leading urinary tract infection testing market players are
- F. Hoffmann-La Roche Ltd
- Sysmex Corporation
- Cardinal Health
- Bio-Rad Laboratories Inc.
- ACON Labs.